Aims: Evidence indicates that feeding-related peptides, such as ghrelin, have a role in the rewarding properties of addictive substances like alcohol. Oral alcohol administration significantly suppresses ghrelin. This study was designed to evaluate the effects of two doses of alcohol on ghrelin and examine if ghrelin levels predict the subjective effects of alcohol. Methods: Healthy social drinkers (N = 20) participated in three, randomly assigned, and counterbalanced laboratory sessions. During each session they received a continuous IV infusion of either placebo (saline), low dose (40 mg%) or high dose (100 mg%) of alcohol. Participants were given a standardized, light breakfast 90 min before the start of the infusion. Ghrelin levels [acyl ghrelin (AG) and total ghrelin (TG)] were collected at four time points before, during and after the infusion. Subjective effects of alcohol, using the BAES, were evaluated before, during and after alcohol infusion. Results: IV alcohol significantly reduced AG but not TG levels with no difference between the two doses of alcohol. The percent change (%Δ) in AG suppression was substantial in both high dose (43.4%Δ), and low dose (39.5%Δ) of alcohol. Also, fasting AG and TG levels were significant predictors of alcohol stimulant and sedative effects. Higher fasting ghrelin levels were associated with longer and more intense subjective effects.
INTRODUCTION
Recent evidence indicates that feeding-related peptide systems have a role in the reward mechanism for both natural reward (such as food) and addictive drugs including alcohol (Panagopoulos and Ralevski, 2014) . Ghrelin, a 28-amino acid peptide, produced in the lining of the stomach and pancreas, is the only known orexigenic hormone (Cummings et al., 2004) . In both animals and humans, central and peripheral ghrelin administration stimulates food intake and is related to subjective hunger. Ghrelin receptors have been identified in the hippocampus, in the ventral tegmental area (VTA) and laterodorsal tegmental area (LDT)-areas involved in the rewarding and hedonic properties of food and other substances including alcohol (Mason et al., 2014) . There are two different ghrelin compounds: acyl ghrelin (AG) is active as ghrelin's action is a result of AG binding to the growth hormone secretagogue receptor type 1a (Kojima et al., 1999) . Des-acyl ghrelin (DAG) is produced during the degradation of ghrelin, has no known biological action (Kojima et al., 1999) , and as such has been considered inactive (Delhanty et al., 2012) . There is some growing evidence, however, that suggests DAG may exert its own biological effects (Hotta et al., 2004; Mackelvie et al., 2007) . Ghrelin levels are mostly reported as total ghrelin (total [TG] ), which is a combination of AG and DAG in a ratio of 1:4 to 1:9 but AG and TG levels have also been reported separately.
Ghrelin is involved in the regulation of eating and has been associated with increases in feeling hungry, initiating eating and increased ingestion of calories (Cummings et al., 2004) . Ghrelin levels fluctuate during the day with increases during hunger and fasting (Mackelvie et al., 2007) and sharp decreases shortly after food consumption (Cummings et al., 2004) . Ghrelin administration increases appetite and increases food intake (Wren et al., 2001 ). There are some differences, however, in healthy weight individuals, obese individuals, or those with eating disorders, suggesting that ghrelin dysregulation is associated with abnormalities in eating patterns (Geliebter et al., 2005) .
Acute oral alcohol administration (single dose of about 2-3 standard drinks) has been consistently shown to decrease AG and/or TG levels when compared to water administration (Calissendorff et al., 2005 (Calissendorff et al., , 2006 (Calissendorff et al., , 2012 Zimmermann et al., 2007) . Using juice as a control, a comparison study was conducted where alcohol (~3 standard drinks) was mixed with grapefruit juice and compared to only grapefruit juice (Zimmermann et al., 2007) . Ghrelin (TG) levels decreased after both conditions but significantly more after alcohol with juice administration, and this was thought to be independent of caloric intake. The conclusion was challenged by others (Cummings et al., 2007) who indicated that since the juice contained carbohydrates that suppress ghrelin, and subjects had a meal at least 2 h before the drink, this may have had an additional effect on ghrelin response. A recent study evaluated ghrelin response to alcohol administered intravenously, in order to examine if bypassing the gastrointestinal tract alcohol has the same reducing effects on ghrelin (Leggio et al., 2013) . Ethanol (target 50 mg% alcohol) or placebo (saline) was randomly administered using a clamp method on different test days. Although alcohol blunted the rise of ghrelin levels, the difference from baseline was not statistically significant.
Most, but not all (Kraus et al., 2005) , studies show that active drinkers have reduced TG and AG levels (Addolorato et al., 2006; Badaoui et al., 2008) . Abstainers have higher TG (Wurst et al., 2007) and AG levels (Koopmann et al., 2012) than controls, and higher TG levels than active drinkers (Leggio et al., 2012) . There is a positive relationship between AG levels and abstinence (Koopmann et al., 2012) , with higher AG levels being associated with longer abstinence. Higher TG levels are also associated with stronger craving for alcohol (Addolorato et al., 2006; Leggio et al., 2011) although not all studies have shown this (Kraus et al., 2005) . This has been shown in alcohol administration studies and ghrelin administration studies (Leggio et al., 2014) (Panagopoulos and Ralevski, 2014) . For example, (Leggio et al., 2014) have shown that ghrelin administration in the laboratory increased alcohol craving in non-treatment seeking individuals who met criteria for alcohol dependence (AD).
Taken together the existing literature suggests that ghrelin levels decrease in response to oral alcohol administration and ghrelin levels are linked to alcohol craving and consumption. Only one study, using a single dose of alcohol compared to placebo, has examined the effects of peripheral (IV) alcohol administration on ghrelin levels (Leggio et al., 2013) and found that IV alcohol did not significantly reduce TG levels in healthy humans. No study to date has examined the relationship between ghrelin levels and the subjective effects of alcohol in healthy subjects. The present study was designed to: (a) examine the effects of intravenous infusion (IV) of two doses of alcohol, high dose 100 mg%, low dose 40 mg% and compared it to placebo (saline) on AG and TG levels; and (b) explore if AG and/or TG levels are related to the subjective effects of alcohol.
METHOD

Subjects
Participants were part of a larger study that examined the effects of family history on the subjective effects of alcohol (Kerfoot et al., 2013) . This study was implemented shortly before the larger study was completed, and a consecutive sample of 20 participants was recruited. The study was approved by the Yale University Human Subjects Committee (HIC) and VA Healthcare Human Subjects Subcommittee (HSS). All participants signed consent before any procedures were performed. The sample for the current project (N = 20) were male and female social drinkers, between the ages of 21 and 30 years old, who had no Axis I disorders (except alcohol abuse), had no history of counseling or psychotherapy, did not have a positive urine toxicology on test days for marijuana, cocaine, benzodiazepines, amphetamines and opiates, negative pregnancy test for females; all subjects were willing to remain alcohol free for 48 h before testing, were not alcohol naïve, had consumed alcohol on a single occasion within the last year (at least the amount equivalent to the high dose of alcohol administered in this study), were medically and neurologically healthy as determined by history, psychiatric and medical evaluation at the start of the study.
Procedures
All subjects participated in three randomly assigned and counterbalanced test days that were each at least 3 days apart. They received two doses of alcohol, high dose with a targeted breath alcohol level (BrAC) of 100 mg% (21.7 mmol/l), low dose with BrAC of 40 mg% (8.68 mmol/l) and placebo (saline). Participants were instructed to fast overnight. Laboratory sessions were conducted on the Biological Studies Unit at the VA Connecticut Healthcare System in West Haven, CT, USA. All participants arrived on the unit at 8:00 am (provided urine samples for toxicology and were breathalyzed) and all procedures started around 9:00 am (for details on study procedures please see Fig. 1 ). All participants were provided with a light breakfast 30 min after arrival consisting of prepackaged ≈ 24.8 g of cereal (average calories ≈ 88.3), 8 oz of milk and 4 oz of orange juice (total ≈ 238.3 calories) and a snack 1 h following breakfast consisting of 4 oz of orange juice and 0.5 oz of Graham crackers (total ≈ 124.1 calories). Infusion began after set up and all doses were infused over~20 min until the targeted BrAC was achieved (Kerfoot et al., 2013 ; http://onlinelibrary.wiley.com/doi/10. 1111/acer.12199/epdf). After the required BrAC was achieved the dose was clamped and maintained for an additional 60 min (for details on clamp procedure see O'Connor et al., 1998 O'Connor et al., , 2000 Ramchandani et al., 1999) Participants were released from the unit after being cleared by a physician and had BrAC levels ≤20 mg%.
Ghrelin levels
Plasma samples were collected when subjects arrived on the unit (−140 min), before infusion (−32 min), during the infusion (+50 min after target alcohol level is reached at time point 0) and following the infusion (+80 min). Blood samples were collected into 4 ml EDTA chilled vacutainers. After the blood was drawn 0.384 ml of 4-(2-aminoethyl) benzenesulfonyl fluoride (AEBSF) solution was pipetted into the 4 ml tube and immediately spun for 15 min at 3000 rpm and 4°C (the AEBSF was diluted to a 42 mmol solution and kept in an ice bath throughout the day). Once the tube was spun, the plasma was pipetted into two separate chilled, preloaded aliquot tube containing 1N hydrochloride acid (HCL) in a 5:1 ratio (generally 1 ml of serum was added 0.2 ml of HCI). These aliquot tubes were frozen at −80°C. Samples were analyzed using Elisa kits for both AG (#EZGRA-88K, Millipore) and TG (#EZGRT-89K, Millipore) human ghrelin. The results were plotted on a sigmoidal 5-parameter logistic equation to determine the ghrelin concentration (pg/ml) of each sample.
Blood alcohol levels (mg/dl)
Blood levels were collected at baseline (−140), during infusion (+50), 20 min (+80) and 50 min (+ 110) after the end of the infusion.
Subjective measures of alcohol effects
All subjective ratings were collected at 8 time points: −140 (shortly after arrival), −32 (shortly before start of infusion), −20 (before target is reached at 0 min), +30, +50, +80, +110, +140 and +200 (all following target). The time points for all subjective measures were adopted from the original study. The Biphasic Alcohol Effects Scale (BAES) (Martin et al. 1993 ), a 14-item measure was used to assess the stimulant and sedative effects of alcohol. The Visual Analogue Scale (VAS) consisted of descriptive words rated on a scale of 0-7. Each single-item consisting of the words 'high', 'buzzed', 'drowsy' and 'tired' is rated for the extent to which the participant is experiencing each feeling at that particular moment. All of the scales are sensitive to ethanol effects and have been shown to have good convergent validity with similar scales.
Data analysis
Data were analyzed in SPSS using mixed models. All tests were twosided at 0.05 level of significance. The Schwarz-Bayesian criterion (BIC) was used to select the best-fitting correlation structure within subjects. Changes in ghrelin levels were assessed using alcohol condition (high dose, low dose, placebo), and time (3 or 4 time points) as within-subject factors. Post hoc test for differences between groups were included in the models. Gender, age (between subject factors) and body mass index (BMI) (as a covariate) were examined as possible predictors of AG and TG response. Subjective alcohol effects were analyzed using alcohol condition (high dose, low dose, placebo) and time (8 time points) as within-subject factors, and fasting AG and TG levels as covariates in all models.
RESULTS
Demographic characteristics
The majority of the sample was Caucasian (70%) and male (60%) with an average age of 24 (SD = 1.8). The sample was college educated (16.3 years of education) and consisted of social drinkers who drank on only 7 days within the last month and consumed an average of 3.3 drinks on one occasion. The majority (85%) of subjects were negative for family history of alcoholism (Table 1) , and had a normal body mass index (BMI) (24.82) with a distribution of 21.1-33.3.
AG levels
There was a statistically significant condition (F 2,1359744 = 9.6, P = 0.0001), time (F 3,816354 = 11.2, P = 0.0001), and a significant condition × time interaction (F 6,84427 = 6.6, P = 0.0001) for AG levels indicating that both low and high alcohol condition significantly reduced AG ghrelin levels over time when compared to placebo Fig. 1 . Outline of study procedures. (Fig. 2 ). There were no statistically significant differences between the two alcohol conditions.
We also calculated percent change in AG levels (%Δ) before alcohol infusion (−32 time point), during (+50) and after alcohol infusion (+80 time point) (Fig. 3) . There was a significant main effect for condition (F 2,12.4 = 23.3, P = 0.0001), and time (F 1,14.0 = 8.8, P = 0.01), but a non-significant (trend) condition × time interaction (F 2,12.3 = 3.5, P = 0.06). Again, there were no statistically significant differences between the two alcohol conditions. The changes in AG levels were robust in the placebo condition (81% increase in AG levels during infusion and 123.8% following the infusion). The high alcohol condition produced a significant and sustained decrease in AG levels during infusion (−43.4%) and following the infusion (−39.5%). Low alcohol condition produced a significant decrease in AG levels during infusion (−31.9%) that was not sustained following the infusion (−5.9%).
TG levels
There was a statistically significant condition (F 2,31.19 = 7.7, P = 0.002), and time (F 3,15.48 = 5.3, P = 0.01) but no significant condition × time interaction (F 6,36.39 = 1.8, P = 0.11) in TG levels. Post hoc analysis revealed that there were no condition differences (two doses of alcohol and placebo) during alcohol infusion (50 time point) (Fig. 4) .
Alcohol caloric content
Because this study used an IV administration procedure exact values for the individual amounts (volume in ml) of infused alcohol were recorded and individual calories for each alcohol dose were estimated. The calculations were based on the following: each 100 ml of solution = 6 g; 1 g of pure alcohol = 7 calories. The amount of alcohol for each subject was calculated based on their body weight, height and gender. The average amount of alcohol for the low dose was 622 ml, and for the high dose was 1063 ml. Consequently, the low dose of alcohol had on average 261.4 calories (range: 174-368) and the high dose of alcohol had almost double the number at 446.2 calories (range: 282-625).
Fasting AG and TG levels
Participants were instructed not to eat from the night before and all reported that they complied with this procedure. There were no significant differences in fasting AG (F 2,27.65 = 0.009, P = 0.9) or TG (F 2,20.01 = 0.1.94, P = 0.2) levels between test days. Since there were no significant mean baseline differences the three baseline values were averaged to create a single baseline fasting AG and TG level for each subject. The distributions of overall fasting AG and TG levels (−140 time point) in this study were wide and were negatively skewed. The average AG level was 176.64 (SD = 138.79) and ranged from 17.67 to 495.47. The average TG level was 334.77 (SD = 167.85) and ranged from 108.37 to 704. 47. The overall fasting AG and TG levels were used as predictors in all subsequent analyses.
Predictors of ghrelin response
Since individual differences in AG and TG levels have been reported based on gender, BMI and age we also examined differences in ghrelin response based on those variables. There were no significant effects of gender (a trend) (P = 0.06), BMI (P = 0.92) or age (P = 0.55).
Subjective alcohol effects
BAES
For this group of participants alcohol produced significant sedative (time, F 7,51.54 = 3.0, P = 0.01), and stimulant effects over time (time, F 7,42 .48 = 5.3, P = 0.0001). Also, there were significant condition differences in the sedative effects (condition, F 2,35.07 = 6.1, P = 0.005) but not in stimulant effects (condition, F 2,40.08 = 0.2, P = 0.8) when compared to placebo. The two-way interaction (time × condition) was significant for stimulant (F 14,83 .31 = 1.7, P = 0.05) but not sedative effects (F 14,67 .0 = 1.5, P = 0.14). Fig. 3 . Percent change from baseline for ghrelin levels after two doses of alcohol and placebo. Placebo induced robust increases in ghrelin levels in terms of percent change from baseline. Conversely, IV alcohol resulted in a significant suppression of ghrelin levels in terms of percent change from baseline. Fig. 4 . Total ghrelin levels for two doses of alcohol and placebo over time. There was no statistically significant difference between the two doses of alcohol and placebo in total ghrelin levels during alcohol infusion (+50 timepoint).
VAS
The analysis of VAS 'high', 'buzzed', 'drowsy' and 'tired' produced, in each case, significant main effects for time (P < 0.001), condition (P < 0.002) and significant two-way interactions (time × condition) (P < 0.03) indicating further that alcohol produced the expected subjective effects in a dose related fashion.
BrAC level
The BrAC values were confirmed using blood alcohol levels (BAL). At +50 time point the average BAL on low dose of alcohol was 45.7 (SE = 1.8), and on high dose of alcohol was 107.8 (SE = 1.9).
Fasting AG and TG as predictors of subjective alcohol effects BAES Fasting AG levels were a significant predictor of sedative alcohol effects measured by the BAES sedative subscale (time × condition × fasting ghrelin F 14,60.5 = 4.2, P = 0.0001) indicating that subjects with higher fasting AG levels were more likely to experience the sedative effects of alcohol longer and with more intensity than those with lower fasting AG levels. Those differences are illustrated in Fig. 5 which depicts the group with higher vs. lower fasting ghrelin levels. The groups were divided based on data distribution. The lower ghrelin group contained (n = 12) individuals with ghrelin levels ranging from 17.67 to 132.0 while the higher ghrelin group contained individuals (n = 8) with ghrelin levels ranging from 193.1 to 459.4.
The results were the same when TG fasting levels were used as a covariate. Fasting AG levels did not predict stimulant effects of alcohol measured by the BAES stimulant subscale (time × condition × fasting AG F 14,77.97 = 0.7, P = 0.7). However, fasting TG levels were a significant predictor of stimulant effects of alcohol (time × condition × fasting TG F 14,64.47 = 1.9, P = 0.04) indicating that subjects with higher fasting TG levels were more likely to experience the stimulant effects of alcohol longer and with more intensity than those with lower fasting TG levels. Of note is that no relationship between fasting ghrelin, and baseline (pre-infusion) subjective stimulant (P = 0.1) or sedative effects (P = 0.3) was observed.
VAS
Fasting AG levels were a significant predictor of feeling 'buzzed' (time × condition × fasting AG F 14,83.59 = 1.9, P = 0.02), feeling 'drowsy' (time × condition × fasting AG F 14,70.51 = 2.6, P = 0.003), and feeling 'tired' (time × condition × fasting AG F 14,72.3 = 2.6, P = 0.004). In all instances those with higher fasting AG levels were more likely to experience these subjective alcohol effects longer and with more intensity than those with the lower fasting AG levels. Fasting AG levels were not a significant predictor of feeling 'high' (time × condition × fasting AG F 14,33.3 = 0.9, P = 0.5). Analysis using fasting TG levels produced similar results.
DISCUSSION
This study is the first to examine the effects of two doses of alcohol administered by IV on AG and TG levels, and to evaluate if AG and TG levels are related to subjective effects of alcohol. The main findings were: (a) IV alcohol significantly suppressed AG but not TG levels, (b) there were no significant differences between the two doses of alcohol on AG levels and (c) fasting AG and TG levels were correlated with more intense subjective alcohol effects based on several measures including BAES and VAS.
Our findings show that alcohol given intravenously reduces AG levels similarly to the reduction seen with oral alcohol administration of about 2-3 standard drinks. Our findings suggest that IV alcohol, even bypassing the stomach, was able to significantly reduce ghrelin with an effect similar to oral administration. One possible explanation, as others have suggested (Leggio et al., 2013) , is that ghrelin action is via the vagal system. When ghrelin binds to its receptor vagus nerve activation occurs that in turn suppresses ghrelin secretion (Ueno and Nakazato, 2016) . Since alcohol also activates the vagus nerve (Nadareishvili et al., 2004) , it is possible that alcohol suppresses ghrelin secretion through this system. Arguably, sharp reduction in ghrelin via the vagal system activation, similar to the gastric and portal effect, occurs regardless of alcohol dose and this is one possible reason we did not detect dose related ghrelin suppression in this study.
Further, since there was not a dose effect response to alcohol it is possible that ghrelin suppression was not due purely to caloric intake Fig. 5 . BAES sedative scores for individuals with low and high fasting ghrelin levels. Those with higher fasting AG levels are more likely to experience the sedative effects of alcohol longer and more intensely than those with lower fasting AG levels.
as others have suggested (Nedvidkova et al., 2003) . The high dose of alcohol had almost double the calories when compared to the low dose of alcohol (261.4 calories for low dose and 446.2 calories for high dose). If ghrelin suppression was based purely on the caloric value of alcohol, differences in ghrelin suppression between the high and low dose of alcohol should have differed; in fact, there were no differences. This is supported by the food literature that shows meals high in carbohydrate suppress ghrelin significantly more than equivalent (caloric) (Monteleone et al., 2003) and nonequivalent meals high in fat (Williams and Cummings, 2005) . We acknowledge that a better test of this hypothesis would have been to control for the individual calories derived from the breakfast and snack. Although all subjects were given a standardized breakfast and snack, the amount of food they consumed was not recorded so the exact number of calories derived from the food could not be determined.
These findings differ from the results reported by (Leggio et al., 2013) who conducted the only other study that measured ghrelin after IV infusion of a single dose of alcohol. Leggio et al. showed that a low dose of alcohol (BrAC = 50 mg%) had only a small (9.6% change in ghrelin) and not statistically significant blunting effect on ghrelin TG levels. Some differences in procedures could have attributed to differences in findings. One difference was the length of alcohol infusion, 60 min in our study vs. 165 min in Leggio et al. It is difficult to speculate, at this point, whether alcohol when infused continuously and for long periods of time loses the strength to blunt the natural rise in ghrelin levels. Also, since Leggio et al. sampled ghrelin only once (+180 at the end of infusion), 3 h after the last meal, it is possible the alcohol effects from a low dose of alcohol were either missed or not detected due to the natural rise of fasting ghrelin. In contrast, we sampled ghrelin at multiple time points, and collected ghrelin 2 h following a snack (total ≈ 124 calories), and 3 h following breakfast (total ≈ 238 calories). Also, differences in ghrelin preparation could attribute, as others have noted (Leggio et al., 2013) , to inconsistencies in ghrelin literature in humans.
The results from this study suggest that fasting AG and TG levels predicted subjective sedative and stimulant effects of alcohol. Those with higher fasting AG and TG levels were more likely to experience the sedative and stimulant effects of alcohol longer and more intensely than those with lower fasting AG levels. This is the first study to report a relationship between fasting AG and TG levels and subjective alcohol effects and suggest that differences in ghrelin levels may be associated with differences in sensitivity to alcohol. A link between ghrelin levels and reward have been reported in the food literature. Higher fasting ghrelin levels have been associated with increased preference for high calorie food and this is positively related to higher reward system activation in imaging studies (Goldstone et al., 2009) . Also, individuals with high fasting ghrelin levels have a stronger brain reward activation to palatable food than those with lower fasting ghrelin levels (Kroemer et al., 2013) . Finally, there is a strong positive relationship between sensitivity to reward and preference for palatable food (Beaver et al., 2006) . This has been linked to higher food consumption and may be a major cause of obesity. One can therefore speculate that higher fasting ghrelin levels may also be associated with higher reward for alcohol. In other words, processes that underline the observation that higher ghrelin levels increase the rewarding properties of food may also increase the rewarding properties of alcohol. This connection has been based on the hypothesis that the same reward mechanisms are involved in the reward for food and addictive drugs. The role of the mesolimbic dopamine pathway in reward for food and drugs of abuse has been well documented, and as others have shown, ghrelin is directly implicated in the release of dopamine (Jerlhag et al., 2007) .
Ghrelin levels have been shown to be higher in women although not all studies show this (Makovey et al., 2007) . Also ghrelin levels are related to BMI (inverse relationship with BMI > 35- Langenberg et al., 2005; Makovey et al., 2007) and age (decrease with age > 45- Makovey et al., 2007) . The study sample was homogenous in terms of age and BMI, perhaps limiting its generalizability; further the small sample size limited the ability to detect gender differences. Other limitations include the use of a saline control; use of an intravenous solution with caloric values identical to the alcohol infusion would be a better control to isolate the effects of alcohol unrelated to caloric load on ghrelin secretion.
In conclusion, this study provides preliminary evidence that ghrelin has a role in the rewarding mechanism for alcohol. The study extends previous research that alcohol suppresses ghrelin levels using AG and is the first to show that fasting AG and TG levels predict subjective alcohol effects in healthy subjects. This is an intriguing finding that needs further replication.
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